Literature DB >> 21776408

Characterization of ATF2 in Rel/NFκB oncogenesis reveals its role in the regulation of Ras signaling.

Andrew S Liss1, Henry R Bose.   

Abstract

The v-Rel oncoprotein is the acutely transforming member of the Rel/NFκB family of transcription factors. v-Rel transforms cells through the inappropriate activation and suppression of genes normally regulated by cellular Rel/NFκB family members. We have recently demonstrated that activation of Ha-Ras by v-Rel contributes to transformation. Characterization of AP-1 family members in v-Rel-mediated transformation revealed ectopic expression of ATF2 inhibited transformation by blocking Ha-Ras activity. This lack of Ha-Ras activity prevented downstream activation of the Raf-MEK-ERK pathway, a critical pathway for v-Rel-mediated transformation. Microarray analysis of cells treated with an inhibitor to the ERK pathway revealed a relatively small number of genes that are specifically regulated by ERK activity in cells expressing v-Rel. These studies suggest the main contribution of ERK activity is to temper the expression of genes in v-Rel transformed cells. The mechanism by which ATF2 regulates Ras-Raf-MEK-ERK signaling appears to be a context dependent event. The ectopic expression of ATF2 in cells that are not expressing v-Rel results in the activation of Ha-Ras. However, activation of downstream Raf-MEK-ERK signaling pathway is blocked, likely through the recruitment of inhibitory 14-3-3 proteins to c-Raf. These results suggest a diverse role for ATF2 in the regulation of the Ras-Raf-MEK-ERK pathway.

Entities:  

Year:  2011        PMID: 21776408      PMCID: PMC3136910          DOI: 10.4161/sgtp.2.2.15310

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  31 in total

1.  Phosphorylation and regulation of Raf by Akt (protein kinase B).

Authors:  S Zimmermann; K Moelling
Journal:  Science       Date:  1999-11-26       Impact factor: 47.728

Review 2.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  The activation of TC10, a Rho small GTPase, contributes to v-Rel-mediated transformation.

Authors:  S Tong; A S Liss; M You; H R Bose
Journal:  Oncogene       Date:  2006-10-02       Impact factor: 9.867

4.  The p38 transduction pathway in prostatic neoplasia.

Authors:  M Ricote; I García-Tuñón; F Bethencourt; B Fraile; P Onsurbe; R Paniagua; M Royuela
Journal:  J Pathol       Date:  2006-02       Impact factor: 7.996

5.  Activation of cyclin D1 by estradiol and spermine in MCF-7 breast cancer cells: a mechanism involving the p38 MAP kinase and phosphorylation of ATF-2.

Authors:  Joan S Lewis; Veena Vijayanathan; T J Thomas; Richard G Pestell; Chris Albanese; Michael A Gallo; Thresia Thomas
Journal:  Oncol Res       Date:  2005       Impact factor: 5.574

6.  PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice.

Authors:  George Poulogiannis; Rebecca E McIntyre; Maria Dimitriadi; John R Apps; Catherine H Wilson; Koichi Ichimura; Feijun Luo; Lewis C Cantley; Andrew H Wyllie; David J Adams; Mark J Arends
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

7.  Slug/Snai2 is a downstream mediator of epidermal growth factor receptor-stimulated reepithelialization.

Authors:  Donna F Kusewitt; Changsun Choi; Kimberly M Newkirk; Pascale Leroy; Yafan Li; Miquella G Chavez; Laurie G Hudson
Journal:  J Invest Dermatol       Date:  2008-08-14       Impact factor: 8.551

8.  Suppressor role of activating transcription factor 2 (ATF2) in skin cancer.

Authors:  Anindita Bhoumik; Boris Fichtman; Charles Derossi; Wolfgang Breitwieser; Harriet M Kluger; Sean Davis; Antonio Subtil; Paul Meltzer; Stan Krajewski; Nic Jones; Ze'ev Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-28       Impact factor: 11.205

9.  Cell transformation by v-Rel reveals distinct roles of AP-1 family members in Rel/NF-kappaB oncogenesis.

Authors:  A S Liss; R Tiwari; J Kralova; H R Bose
Journal:  Oncogene       Date:  2010-06-21       Impact factor: 9.867

10.  ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents.

Authors:  H van Dam; D Wilhelm; I Herr; A Steffen; P Herrlich; P Angel
Journal:  EMBO J       Date:  1995-04-18       Impact factor: 11.598

View more
  1 in total

1.  Aspirin inhibits epithelial-to-mesenchymal transition and migration of oncogenic K-ras-expressing non-small cell lung carcinoma cells by down-regulating E-cadherin repressor Slug.

Authors:  Poulami Khan; Argha Manna; Shilpi Saha; Suchismita Mohanty; Shravanti Mukherjee; Minakshi Mazumdar; Deblina Guha; Tanya Das
Journal:  BMC Cancer       Date:  2016-01-26       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.